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Should oral immunotherapy be contraindicated in patients with eosinophilic esophagitis if IgE-mediated food allergy develops after dietary elimination to treat EoE?
Stephanie C. Erdle (EoE) . We question whether OIT should be contraindicated if food allergy results from EoE treatment, if patients prefer the outcome of EoE over the possibility of anaphylaxis. METHODS: Epicutaneous testing to cow's milk was performed prior to dietary elimination and after onset of IgE-mediated symptoms, followed by subsequent oral food challenge (OFC). RESULTS: A 5-year-old girl with EoE had negative epicutaneous testing to cow's milk prior to dietary elimination. Following one year of elimination, biopsies showed substantial reduction in eosinophilia, but accidental exposure to 1 tsp of cow's milk shortly thereafter resulted in immediate urticaria. Her mother subsequently gave her small amounts of dairy on a regular basis, with isolated oral pruritus. Four months after the initial accidental exposure, epicutaneous testing was positive at 10x4mm, increasing to 20x6mm two months later. A 120 mL cow's milk OFC was tolerated without adverse reaction, and the impression was desensitization (''home-based OIT''). She was advised to continue to ingest small amounts daily to both prevent the development of anaphylaxis and reduce the risk of EoE recurrence. Since starting this, her EoE has been clinically stable. CONCLUSIONS: We propose a continuum of immune responses to cow's milk with shifting phenotypes from potentially anaphylactic IgEmediated allergy (when strictly avoiding milk) to EoE (when regularly ingesting milk), with the ideal of finding a balance where patients could ingest small amounts of milk to prevent anaphylactic allergy, while maintaining control of EoE.
Allergen Immunotherapy as a Treatment Modality for Eosinophilic Esophagitis
Robert H. Wauters, Walter Reed, NMMC, U. S. Navy, bethesda, MD, and Cecilia Mikita, MD MPH FAAAAI; Walter Reed National Military Medical Center, Bethesda, MD. RATIONALE: Eosinophilic Esophagitis (EoE) is a well-recognized chronic immune mediated disease characterized by inflammation of the esophagus. Elimination diets and medical therapy with proton pump inhibitors (PPI) or swallowed steroids have been the standard of care, with varying degrees of clinical improvement. METHODS: N/A -Case Report RESULTS: A nine year old girl with long history of atopic disease presents to allergy clinic to establish care. Diagnoses include allergic rhinitis, asthma, food allergy, atopic dermatitis, and EoE, which was diagnosed at 18 months of age. Initial presenting symptoms consisted of esophageal reflux, poor weight gain, and severe atopic dermatitis. Diagnostic endoscopy revealed 72 eosinophils/hpf. Diagnostic criteria for EoE was met. Skin prick and serum IgE testing to food and aeroallergens was performed, and subsequent treatment with aggressive elimination diet of 23 foods and PPI was initiated. She improved clinically, and her trending endoscopy a year later showed 0 eosinophils/ hpf. Attempts to wean pharmacotherapy and reintroduce previously eliminated foods over the ensuing years resulted in recurrence of symptoms and esophageal eosinophilia. In consultation with pediatric gastroenterology and the patient's family, the decision was made to pursue aeroallergen immunotherapy (AIT). AIT improved the patient's allergic rhinitis, EoE symptoms abated, and a repeat upper endoscopy performed approximately 2 months after reaching maintenance dose AIT showed 0 eosinophils/ hpf. Interestingly, the patient's atopic dermatitis did not improve significantly on AIT. CONCLUSIONS: This patient's case demonstrates the potential of AITas a promising treatment modality for patients with EoE and concomitant allergic rhinitis.
